|
|
||||
|
MYC requirement
Email: Jonathan B Weitzman - jonathanweitzman@hotmail.com News from The Scientist 2002, 3(1):20020708-01
|
||||
|
|
||||
|
There is increasing evidence that sustained oncogene expression may be required to maintain the cancer state, implying that therapeutic strategies that use transient pharmacological inactivation may prove effective. In the 5 July Science, Meenakshi Jain and colleagues describe an elegant experimental model to explore the effect of brief oncogene inactivation (Science 2002, 297:102-104).
|